Poland · Delayed Price · Currency is PLN Diagnostyka Statistics
Total Valuation
Diagnostyka has a market cap or net worth of PLN 5.46 billion. The enterprise value is 6.54 billion.
| Market Cap | 5.46B |
| Enterprise Value | 6.54B |
Important Dates
The last earnings date was Monday, April 20, 2026.
| Earnings Date | Apr 20, 2026 |
| Ex-Dividend Date | Jun 1, 2026 |
Share Statistics
Diagnostyka has 33.76 million shares outstanding. The number of shares has increased by 0.05% in one year.
| Current Share Class | 33.76M |
| Shares Outstanding | 33.76M |
| Shares Change (YoY) | +0.05% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 51.42% |
| Owned by Institutions (%) | 27.15% |
| Float | 16.40M |
Valuation Ratios
The trailing PE ratio is 21.69 and the forward PE ratio is 17.00. Diagnostyka's PEG ratio is 0.50.
| PE Ratio | 21.69 |
| Forward PE | 17.00 |
| PS Ratio | 2.25 |
| PB Ratio | 9.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.72 |
| P/OCF Ratio | 9.89 |
| PEG Ratio | 0.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.19, with an EV/FCF ratio of 18.84.
| EV / Earnings | 25.98 |
| EV / Sales | 2.70 |
| EV / EBITDA | 11.19 |
| EV / EBIT | 17.09 |
| EV / FCF | 18.84 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 1.97.
| Current Ratio | 0.73 |
| Quick Ratio | 0.58 |
| Debt / Equity | 1.97 |
| Debt / EBITDA | 1.85 |
| Debt / FCF | 3.11 |
| Interest Coverage | 5.56 |
Financial Efficiency
Return on equity (ROE) is 53.41% and return on invested capital (ROIC) is 20.48%.
| Return on Equity (ROE) | 53.41% |
| Return on Assets (ROA) | 12.63% |
| Return on Invested Capital (ROIC) | 20.48% |
| Return on Capital Employed (ROCE) | 24.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 280,420 |
| Profits Per Employee | 29,104 |
| Employee Count | 7,836 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 8.85 |
Taxes
In the past 12 months, Diagnostyka has paid 55.01 million in taxes.
| Income Tax | 55.01M |
| Effective Tax Rate | 17.36% |
Stock Price Statistics
The stock price has decreased by -2.38% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.38% |
| 50-Day Moving Average | 169.55 |
| 200-Day Moving Average | 182.69 |
| Relative Strength Index (RSI) | 48.78 |
| Average Volume (20 Days) | 104,457 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Diagnostyka had revenue of PLN 2.42 billion and earned 251.60 million in profits. Earnings per share was 7.45.
| Revenue | 2.42B |
| Gross Profit | 1.92B |
| Operating Income | 382.70M |
| Pretax Income | 316.88M |
| Net Income | 251.60M |
| EBITDA | 584.50M |
| EBIT | 382.70M |
| Earnings Per Share (EPS) | 7.45 |
Balance Sheet
The company has 18.42 million in cash and 1.08 billion in debt, with a net cash position of -1.06 billion or -31.47 per share.
| Cash & Cash Equivalents | 18.42M |
| Total Debt | 1.08B |
| Net Cash | -1.06B |
| Net Cash Per Share | -31.47 |
| Equity (Book Value) | 547.19M |
| Book Value Per Share | 15.65 |
| Working Capital | -138.08M |
Cash Flow
In the last 12 months, operating cash flow was 551.77 million and capital expenditures -204.78 million, giving a free cash flow of 346.99 million.
| Operating Cash Flow | 551.77M |
| Capital Expenditures | -204.78M |
| Depreciation & Amortization | 201.79M |
| Net Borrowing | -98.26M |
| Free Cash Flow | 346.99M |
| FCF Per Share | 10.28 |
Margins
Gross margin is 79.17%, with operating and profit margins of 15.79% and 10.38%.
| Gross Margin | 79.17% |
| Operating Margin | 15.79% |
| Pretax Margin | 13.07% |
| Profit Margin | 10.38% |
| EBITDA Margin | 24.11% |
| EBIT Margin | 15.79% |
| FCF Margin | 14.31% |
Dividends & Yields
This stock pays an annual dividend of 3.31, which amounts to a dividend yield of 2.10%.
| Dividend Per Share | 3.31 |
| Dividend Yield | 2.10% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.41% |
| Buyback Yield | -0.05% |
| Shareholder Yield | 2.05% |
| Earnings Yield | 4.61% |
| FCF Yield | 6.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Diagnostyka has an Altman Z-Score of 4.18 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.18 |
| Piotroski F-Score | 6 |